Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40621

EFCAB7 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The EFCAB7 Knockout HeLa Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population in the HeLa cervical adenocarcinoma line, targeting the ciliary nexin-dynein regulatory complex subunit EFCAB7. This model disrupts a calcium-binding EF-hand protein that interacts with N-DRC partners (DRC1?C7) and radial spoke proteins to modulate dynein-driven ciliary motility. Loss of EFCAB7 enables functional studies of N-DRC assembly, calcium-dependent ciliary regulation, and ciliopathy mechanisms. With inducible ciliogenesis, these cells support immunofluorescence, co-immunoprecipitation, motility assays, and signaling analyses, making them a valuable tool for ciliary biology and calcium signaling research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    EFCAB7

    Gene Identifier

    NCBI Gene ID 84455

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The EFCAB7 Knockout HeLa Polyclonal Cells product consists of a CRISPR/Cas9-edited polyclonal knockout population of HeLa cells, designed to abrogate functional expression of the EFCAB7 gene. This heterogeneous pool provides a robust loss-of-function model for investigating EFCAB7, an EF-hand calcium-binding protein that serves as a subunit of the nexin-dynein regulatory complex (N-DRC) in cilia and flagella. By eliminating endogenous EFCAB7, researchers can dissect its contributions to ciliary motility, calcium-dependent regulatory mechanisms, and associated pathways without the need for clonal isolation. The polyclonal format ensures broad applicability across various cell biology assays while maintaining genetic diversity.

HeLa cells, originated from a human cervical adenocarcinoma in 1951, are a cornerstone of biomedical research due to their immortalized growth, ease of culture, and extensive characterization. These adherent epithelial cells have been pivotal in studies of cancer biology, virology, and signal transduction. Although normally non-ciliated, HeLa cells can be induced to form primary cilia upon serum withdrawal, providing an experimentally tractable system for studying ciliary proteins like EFCAB7 in a cancer cell background. This inducible ciliogenesis makes HeLa a suitable host for dissecting ciliary assembly and function.

EFCAB7 encodes an evolutionarily conserved EF-hand domain-containing protein that localizes to ciliary axonemes, where it functions as a core N-DRC component. The N-DRC connects outer doublet microtubules and coordinates dynein arm activity to generate ciliary bending. EFCAB7 interacts directly with other DRC subunits (DRC1?CDRC7), radial spoke head proteins, and dynein heavy chains. Its EF-hand motifs likely bind calcium, triggering conformational changes that modulate dynein-driven microtubule sliding and beat frequency. Transcriptionally, EFCAB7 expression is controlled by ciliogenic factors such as RFX2, RFX3, and FOXJ1, which regulate ciliary gene programs. Downstream, N-DRC function influences inner and outer dynein arms and, through ciliary integrity, can impact Hedgehog signaling.

In the HeLa context, EFCAB7 knockout cells offer a clean platform to study N-DRC assembly and calcium-sensitive motility regulation. Inducible ciliogenesis enables temporal analyses of complex formation and functional assays without interference from wild-type protein. The cancer background may also facilitate exploration of any non-ciliary roles of EFCAB7. As a polyclonal pool, these cells reduce clonal bias and more accurately represent population-level responses, enhancing reproducibility in studies requiring large numbers of cells.

These knockout cells support diverse applications: immunofluorescence microscopy of ciliary markers following serum starvation, co-immunoprecipitation to map N-DRC interactions, Western blotting and qRT-PCR for expression validation, calcium imaging to assess EF-hand functionality, and ciliary motility assays using high-speed video microscopy. The model is valuable for investigating ciliopathies like primary ciliary dyskinesia and for elucidating calcium signaling in ciliary contexts. For product inquiries or a quotation, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)